Now I'll synthesize the final consolidated review.

## Summary

This paper proposes an end-to-end multi-view diabetic retinopathy (DR) grading framework that internally generates lesion proposals (GALP module) and uses them for cross-view fusion via gated MoE and top-K-weighted attention (LGRF module). The core idea — replacing external lesion annotations with self-derived proposals to reduce annotation dependence — is sensible and practically motivated. Experiments on two multi-view DR datasets (MFIDDR and DRTiD) show that the lesion-free variant achieves 83.9% accuracy on MFIDDR, surpassing all end-to-end baselines and rivaling externally informed methods, and 76.0% on DRTiD, outperforming all comparison methods including CrossFIT.

## Strengths

1. **Well-motivated method with clear architectural novelty.** The idea of generating grade-conditioned evidence maps (GEMs) from auxiliary classifiers and using the top-K regions as self-derived lesion proposals is clean and original. The LGRF module's gated expert routing conditioned on cross-view context is a principled design for selective fusion. The framework is end-to-end trainable and requires no external annotations at inference, which is a genuine practical advantage.

2. **Strong empirical results on two benchmarks.** On MFIDDR (Table 1), the lesion-free variant (83.9% accuracy, 70.9 kappa, 83.5 F1) surpasses all end-to-end baselines (best: ETMC at 81.5%) and several externally informed methods (e.g., CVSA at 82.6%, LFMVDR at 82.2%). On DRTiD (Table 3), the method achieves 76.0% accuracy, outperforming CrossFIT (75.6%) and all other methods. These results establish that self-generated proposals can substitute for costly external annotations to a meaningful degree.

3. **Ablation study confirms module contributions within the same backbone.** Table 4 shows clear drops when removing GALP (82.7%, −1.2%), removing the expert pool (82.6%, −1.3%), and removing LGRF (82.3%, −1.6%), all relative to the full method (83.9%). Since these ablations share the Swin-B backbone, they provide causal evidence that the proposed modules contribute beyond the backbone choice. The hyperparameter analysis (Fig 3) further reinforces this with the α=1.0 vs α=0.5 comparison isolating the proposal filtering effect (82.9% → 83.9%).

4. **Competitive grade-wise performance.** Table 2 shows the method achieves the best F1 scores on Grade 2 (65.2%), Grade 3 (74.8%), and Grade 4 (51.6%) when using lesion inputs, and competitive performance even without lesions, indicating benefits across all DR severity levels.

## Weaknesses

### Fatal
None.

### Major

1. **Backbone disparity makes the SOTA comparison uninterpretable.** The paper compares its method (Swin-B backbone) against baselines that overwhelmingly use smaller backbones: MVCINN (custom CNN), MVCNN variants (ResNet50/VGG19), RETFound (ViT-L but much smaller absolute performance), CVSA (ResNet50). The ablation provides within-backbone control showing module contributions, which is good — but the headline claim of "SOTA competitiveness without external annotations" relies on cross-backbone comparisons. A simple baseline of "Swin-B + global average pooling + classifier" (or "Swin-B + straightforward cross-view feature concat") is missing. Without this, the reader cannot distinguish how much of the gap over baselines (e.g., 3.8% over MVCINN) is due to GALP/LGRF vs. the backbone itself. This is the single most significant weakness in the paper's evidence chain.

### Minor

1. **No variance or statistical significance reporting.** All results are single-point estimates. The ablation drops (1.0–1.6%) and the gap to the best externally informed method (0.3% below WGLIN) are within the typical run-to-run variance range for deep learning on these datasets. Without standard deviations across multiple seeds, the reader cannot assess whether the observed differences are reliable or noise. While this is common practice among the baselines as well, the paper's core claims would be substantially strengthened by multi-run statistics.

2. **No validation that proposals correspond to lesions.** The paper's motivation rests on the assumption that the selected top-K regions correspond to clinically meaningful lesions (microaneurysms, hemorrhages, etc.). The MFIDDR dataset provides lesion segmentation masks, but no experiment measures proposal overlap with these masks. The GEMs are described but never visualized. This creates a gap between the method's narrative ("lesion proposals") and what is actually demonstrated ("grade-predictive regions"). The grading results show empirical utility, but the core premise remains unverified.

3. **Ablation does not fully isolate the auxiliary loss from proposal selection.** The "w/o GALP" ablation removes both the auxiliary classification loss and the proposal generation. The hyperparameter sweep (α=1.0 vs α=0.5) partially isolates the proposal filtering effect, but there is no setting where GALP is active with all tokens retained (α=1.0) explicitly interpreted as a control — the α=1.0 condition is presented only as part of the hyperparameter study. An explicit ablation isolating the auxiliary loss while keeping proposal selection (or vice versa) would sharpen the attribution.

4. **Missing architectural details for reproducibility.** The Transformer expert architecture (depth, hidden dimension D, number of attention heads) is not specified. The focal loss parameters (γ, α) are not given. These details are needed for reproducibility.

5. **No computational cost comparison.** The MoE and multi-head cross-attention likely add overhead in both parameters and inference time, but the paper reports no FLOPs, parameter counts, or latency comparisons against baselines. This makes it difficult to assess the practical deployment trade-offs.

### Trivial

- Equation (3) uses the notation `𝐰_{s_n, c}^{(s_n)}` where the stage superscript is redundant with the subscript.
- The paper states "we fix r=50%" in Section 4.1 but this variable `r` is not defined — likely a formatting artifact referring to α.

## Nice-to-Haves

- Qualitative visualizations of GEMs and selected proposal regions alongside actual lesion masks would significantly strengthen the paper's claims about proposal quality.
- A limitations paragraph acknowledging that (a) the proposals are based on grade-discriminative regions which may not correspond to all lesion types, (b) the method assumes grade-correlated regions are lesions, and (c) performance may degrade when non-lesion signals drive the classifier.
- A "Swin-B + global concat" baseline to fully control for the backbone.

## Removed Points

- **Reproducibility concern about not releasing the model/code**: No such complaint was made, but any concerns about existence of cited works are removed per hard rules.
- **Criticisms about missing appendix content**: Removed per hard rules (parser strips appendices).
- **Speculation about focal loss parameter sharing (same γ for main and auxiliary)**: The harsh critic raised this as unspecified; it is a valid missing detail but minor enough to fold into Weakness #4 rather than list separately.
- **Criticisms about the patch size q choice not being justified**: The paper states q is chosen to divide spatial dimensions exactly, which is a standard and sufficient justification; removing as strawman.
- **Strength Finder's generic/conflicting strengths**: Removed generic strengths like "the problem is important" and "systematic hyperparameter analysis" was already kept.

## Novel Insights

Beyond the paper's own contributions, the review surfaces two noteworthy observations. First, the paper's ablation and hyperparameter analysis (α=1.0 vs α=0.5) already contains a clean comparison that isolates the proposal filtering effect, but the authors present it only as hyperparameter tuning rather than as an explicit ablation — this is a missed opportunity to strengthen the attribution story. Second, the harsh critic's backbone disparity concern, while real, coexists with a within-backbone ablation that does show module-level contributions; the issue is not that the modules don't work (the ablation shows they do) but that the magnitude of the SOTA claim is inflated by the backbone. This distinction matters because it means the paper's core technical contribution is sound even if the marketing overshoots.

## Suggestions

1. **Add a Swin-B-only baseline**: Replace the standard multi-view fusion with simple concatenation of GAP features (or a single cross-attention layer) while keeping Swin-B and all training settings identical. Report this as a row in Table 1. This would cleanly separate backbone gains from module gains.

2. **Report multi-run statistics**: Run the main experiments (full method, w/o GALP, w/o LGRF, and the Swin-B baseline) at least 5 times with different seeds and report mean ± std. This would address the most immediate evidential concern.

3. **Validate proposals quantitatively**: Use the MFIDDR lesion masks to compute recall or Dice between the top-K proposal regions and actual lesion masks. Show at least one figure with example GEMs and selected proposals alongside ground-truth lesions.

4. **Add a controlled ablation of the auxiliary loss**: Compare (a) full GALP, (b) GALP with α=1.0 (all tokens, proposal selection disabled), and (c) proposal selection without auxiliary loss. This would clarify the role of each component in the 1.2% drop.

5. **Report computational cost**: Add a table comparing FLOPs, parameter count, and/or inference time against key baselines.

## Score and Decision

### Calibration Anchors

**Round 1 (Bracketing):**
- Weak band (avg < 3.5): mkoeblmWvN (2.67, retinal robustness), LxjdknhUen (3.33, multi-view pedestrian), O2Y1laOELd (2.50, multi-view HMR), KuqySLmXad (2.50, emotion learning). *These are clearly weaker — either flawed methodology or unrelated problems.*
- Middle band (3.5 – 7.5): 9gc58FeBba (5.00, multi-view DR interpretability), WuEE1f4NId (4.00, DR concept learning), QCCMvWYwPN (4.50, multimodal ophthalmic dataset), pDu6u9cnEB (6.00, 3D scene understanding).
- Strong band (avg > 7.5): kI27Niy4xY (8.00, text-to-3D), DTQIjngDta (8.00, visual geometry), DM0Y0oL33T (8.00, multimodal verifier). *Unrelated domains, clearly stronger methodology and evaluation.*

**Round 2 (Narrowing within bracket):**
- fRNUftg096 (5.50, retinal UQ benchmark — no method contribution, comparable evaluation rigor)
- 9gc58FeBba (5.00, multi-view DR — synthetic data issues, weaker method)
- Z6KGt1veeP (5.50, Dual-Kernel Adapter — Accept Poster, solid method but derivative novelty)
- i7YnUW0uWg (6.00, pathology segmentation — Accept Poster, thorough evaluation)
- CYmjrbQRyM (6.00, ASMIL — Accept Poster, clean experiments, clear problem identification)

**Relative positioning:** The paper's methodological novelty (self-derived proposals) is stronger than the 5.00/5.50 anchors, and its results are convincing. However, the evaluation lacks the rigor of the 6.00 anchors (ASMIL: multi-run stats, correlation analyses; Dual-Kernel Adapter: extensive ablations). The backbone disparity issue further tempers the confidence in the headline numbers. The paper sits between the 5.50 and 6.00 anchors — better in contribution than the DR interpretability paper (5.00) and the UQ benchmark (5.50), but the evaluation has gaps that the 6.00 papers (ASMIL, pathology segmentation) do not.

**Final score: 5.5**

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>